S. Ina

发表

How Do We Predict the Clinically Relevant Pancreatic Fistula After Pancreaticoduodenectomy?—An Analysis in 244 Consecutive Patients

H. Yamaue, M. Tani, S. Hirono, 2009, World Journal of Surgery.

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy

Yusuke Nakamura, T. Mushiroda, M. Kubo, 2012, Pharmacogenetics and genomics.

CLIP Method (Preoperative CT Image-assessed Ligation of Inferior Pancreaticoduodenal Artery) Reduces Intraoperative Bleeding during Pancreaticoduodenectomy

H. Yamaue, M. Tani, S. Hirono, 2007, World Journal of Surgery.

A prospective randomized controlled trial of internal versus external drainage with pancreaticojejunostomy for pancreaticoduodenectomy.

H. Yamaue, M. Tani, S. Hirono, 2010, American journal of surgery.

Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

H. Yamaue, M. Tani, S. Hirono, 2009, Archives of surgery.

A Central Pancreatectomy for Benign or Low-Grade Malignant Neoplasms

H. Yamaue, M. Tani, S. Hirono, 2009, Journal of Gastrointestinal Surgery.

Pylorus-preserving pancreaticoduodenectomy versus conventional pancreaticoduodenectomy for pancreatic adenocarcinoma

H. Yamaue, M. Tani, S. Hirono, 2009, Surgery Today.

Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma.

S. Hayami, H. Yamaue, M. Ueno, 2009, Journal of hepato-biliary-pancreatic surgery.

Early Removal of Prophylactic Drains Reduces the Risk of Intra-abdominal Infections in Patients With Pancreatic Head Resection: Prospective Study for 104 Consecutive Patients

H. Yamaue, H. Terasawa, M. Tani, 2006, Annals of surgery.

Improvement of Delayed Gastric Emptying in Pylorus-Preserving Pancreaticoduodenectomy: Results of a Prospective, Randomized, Controlled Trial

H. Yamaue, H. Terasawa, M. Tani, 2006, Annals of surgery.

Complications with Reconstruction Procedures in Pylorus-preserving Pancreaticoduodenectomy

H. Yamaue, M. Ueno, H. Terasawa, 2005, World Journal of Surgery.

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome‐wide expression profiling

Y. Miki, T. Noda, H. Yamaue, 2010, Cancer science.

MUC1 Is a Useful Molecular Marker for Malignant Intraductal Papillary Mucinous Neoplasms in Pancreatic Juice Obtained From Endoscopic Retrograde Pancreatography

H. Yamaue, M. Tani, M. Tsutsumi, 2010, Pancreas.

A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age.

H. Yamaue, M. Tani, S. Hirono, 2009, Journal of hepato-biliary-pancreatic surgery.

Liver metastasis as an initial recurrence has no impact on the survival of patients with resectable pancreatic adenocarcinoma

H. Yamaue, M. Tani, S. Hirono, 2009, Langenbeck's Archives of Surgery.

Indication of Hepatopancreatoduodenectomy for Biliary Tract Cancer

H. Yamaue, M. Tani, S. Hirono, 2006, World Journal of Surgery.

Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer.

H. Yamaue, M. Tani, S. Hirono, 2008, Anticancer research.

Identifying Molecular Markers for Chemosensitivity to Gemcitabine in Pancreatic Cancer: Increased Expression of Interferon-Stimulated Gene 15 kd Is Associated With Intrinsic Chemoresistance

T. Noda, H. Yamaue, S. Hirono, 2010, Pancreas.

Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer.

H. Yamaue, H. Terasawa, M. Tani, 2007, Journal of hepato-biliary-pancreatic surgery.

Virus-associated hemophagocytic syndrome and hemorrhagic jejunal ulcer caused by cytomegalovirus infection in a non-compromised host; a case report of unusual entity.

H. Yamaue, M. Tani, K. Takifuji, 2004, Hepato-gastroenterology.